KNOWLEDGE BANK

Interviews

Datwyler Pharma Packaging

Senior Manager Global Scientific Affairs
Renaud Janssen PhD is the Senior Manager of Global Scientific Affairs at Datwyler Pharma Packaging He frequently presents on international conferences on subjects related to elastomeric and aluminiumplastic closures for pharmaceutical applications Renaud also serves on several standardisation and pharmacopoeia committees as well as on industry task forces

Articles

Viksit Bharat@ 2047 envisioned the Indian Pharma Industry

The Indian Pharmaceuticals industry has emerged globally as one of the fastest growing industries The pharmaceutical industry in India is expected to reach Bn by and Bn by The pharmaceutical industry

Research Insights

Functional human genes typically exhibit epigenetic conservation

Recent DepMap CRISPRCas single gene disruptions have identified genes more essential to proliferation in tissue culture It would be valuable to translate these finding with measurements more practical for human tissues Here we show that DepMap essential genes and other literature curated functional

Case Studies

Variation In Adverse Drug Reactions Listed In Product Information For Antidepressants And Anticonvulsants, Between The Usa And Europe: A Comparison Review Of Paired Regulatory Documents

Abstract Objective To compare consistency of adverse drug reaction ADR data in publicly available product information documents for brand drugs between the USA and Europe and to assess the usefulness of information for prescribers and patients Design A comparison review of product info

Techno Trends

Novel Ivonescimab (PD-1/VEGF Bispecific Antibody Developed for Non-Small-Cell Lung Carcinoma (NSCLC) patients

Akeso Biopharma developed novel Ivonescimab PDVEGF bispecific antibody in combination with docetaxel for the treatment of locally advanced or metastatic NonSmallCell Lung Carcinoma NSCLC patients Novel Ivonescimab is applicable for patients who have failed to respond to prior PDL

White Papers

Cloud Computing in the Laboratory Informatics Solutions and Validation Approaches

In the modern business environment, a significant portion of work is conducted using computerized systems. Many solutions are used to complete tasks, including simple desktop programs like email and Microsoft Office to enterprise-wide, global systems like ERP (Enterprise Resource Planning), MES (Manufacturing Execution System), and LIMS

TOP ARTICLES

1

Changing Paradigms in Use of AI in Chemical Sciences

Prashant S. Kharkar

Prashant S. Kharkar, a well-respected Drug Discovery Researcher with rich industrial experience, received his B. Pharm. degree in 1998. He obtained his PG and Ph.D. (Tech.) degrees Institute of Chemical Technology (ICT), Mumbai, India. Dr. Kharkar completed his postdoctoral research (2006–2009) on neurodegenerative diseases and disorders.

Akash S. Sirsat

Akash Sirsat is pursuing M.Tech in Pharmaceutical Chemistry and Technology at the Institute of Chemical Technology (ICT), Mumbai. He completed his Bachelor of Pharmacy from Sinhgad Institute’s SKNCOP, Pune. His research interests include pharmaceutical chemistry, process development, and applications of AI/ML in pharmaceutical synthesis. He has qualified GPAT, GATE, NIPER, and GAT-B.

2

Precision medicine for Alzheimer’s Disease

Dr. Parmi Tripathi

Dr Parmi is a scientific researcher and an expert medical writer with Ph.D specialising in neurosciences. With an extensive pharmaceutical and healthcare industry experience, she excels at driving innovation. Focused at patient’s centricity, she has played key role in developing innovative medicines that makes meaningful impact on patient’s lives. Dr Parmi has made significant contribution at establishing a patented mouth-dissolving strip (MDS) manufacturing facility. With proven expertise in novel product development, her strong emphasis on quality manufacturing has led to structuring of quality documentation practices for this novel & patented MDS technology aligned with regulatory standards.

Dr Parmi has made significant contributions in field of neuroscience research with multiple acclaimed publications. A distinguished medical writer, she serves as editorial board member and peer reviewer in prestigious journals and continuous to make an impact in her field. Author at reputed public health platform, she writes to promote health awareness. Recognised for her exceptional contributions, she is a multiple-time government R&D grant recipient, particularly in neurodegenerative disorder studies.

3

How PBM's Transformed to Provide Easy Access to Prescription Drugs Post COVID 19

Ravi Iyer

Technology Executive - Big Data, Analytics, Cloud, Digital, Elevance Health, Inc.

Narasimha Reddy Nalamalapu

Narasimha is result driven leader with vast experience in executing various PBM, Health care, Financial, and securities trading applications. Technical expertise in Big data, Cloud, Analytics, Mainframe, BPM, testing, and Data warehouse projects at esteemed organizations like Anthem, Tetrasoft, DST, HCL, Deutsche bank, and Atos Origin. He currently works as Solution Architect at Tetrasoft Inc.
.Narasimha has vast experience in Pre-sales, Project management, effective customer communication, Architect, Technical Lead, On-site coordinator, and business Analyst roles for various complex assignments across the globe.

 

4

Redefining Therapeutics

Mads Hald Andersen

Professor Mads Hald Andersen, DMSc, DScTech, PhD, is Director of the National Center for Cancer Immune Therapy, CCIT-DK, at Copenhagen University Hospital Herlev, Denmark. He discovered tumor microenvironment antigens and anti-regulatory T cells and defined their role in immune regulation. He initiated the immune modulatory vaccine concept and has authored more than 250 publications and 25 patents.

5

Magnetic Nanoparticles and their Application Studies on Synthesis Characterisation

Prabhanjan S Giram

Prabhanjan S Giram qualified CSIR-NET AIR-81 in chemical sciences and received his Ph. D from National chemical laboratory, Pune. He Received Eudragit® 2018 Award of 1500 Euros from Evonik health care Germany. He also received newton Bhabha Fellowship from British council, UK and DBT, India. He has expertise in synthesis of biocompatible, biodegradable polymer with rationalised design of nanoformulation, nanofiber, semisolid dosage form such as ointment, creams, and gel.

 

Shubham R Musale

Shubham R Musale has graduate in pharmacy from Savitribai Phule Pune University. He got fellowship for M.pharm from AICTE. The Thesis titled for M.pharm Design of In-expensive Collector for preparation Electrospun Nanofiber. He has 2 review publication and 1 Book Chapter.

 

Sushil Y Raut

Sushil Y Raut has over 12 years of teaching and research experience. He has more than 25 research and review publications. He filed 3 Indian patents and over 20 national as well as international presentations in his credits. He is recipient of international research mobility fellowship and other prestigious awards.

 

press releasesRead more...

Ecolab Opens Advanced Resin Manufacturing Facility in China

Demand for advanced purification solutions is growing as industries look to improve performance while using less water and fewer natural resources Industries are increasingly turning to advanced separation purification

Waters Sets Benchmark for Standardized Spectral Flow Cytometry with Commercial Launch of BD FACSDiscover A7 Cell Analyzer

Waters Corporation NYSE WAT today announced the global commercial launch of the BD FACSDiscover A Cell Analyzer which uniquely combines exceptional spectral resolution and sensitivity with industryleading standardization

Ginkgo Bioworks to Build an Autonomous Lab at Novo’s New U.S. R&D Site in Waltham

Ginkgo Bioworks NYSE DNA today announced that it has been selected to build an autonomous lab powered by its Reconfigurable Automation Cart RAC architecture at Novos new RD site in Waltham Massachusetts

Altruist Biologics Congratulates Partner LongBio Pharma on the BLA Acceptance of LP-003 by the China NMPA

Altruist Biologics a worldclass contract development and manufacturing organization CDMO and wholly owned subsidiary of Innovent Biologics HK congratulates its strategic partner LongBio Pharma

Sanofi and Cheplapharm to create new strategic partnership in mature medicines

Sanofi and Cheplapharm a European leader in wellestablished medicines today announced their intention to create a strategic partnership under which Cheplapharm would take over from Sanofi a selection

Lilly completes acquisition of AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditions

Eli Lilly and Company NYSE LLY today announced the successful completion of its acquisition of AtaiBeckley Inc AtaiBeckley is a clinicalstage biopharmaceutical company developing rapidacting

EventsRead more...

15 - 17

Sep 2026

COPD Drug Development Summit 2026

Street, Boston, MA 02210, USA

21 - 23

Sep 2026

21 - 23

Sep 2026

Cancer R&D World Conference

Hilton Garden Inn Miami Dolphi...

22 - 23

Sep 2026

22 - 24

Sep 2026

28 - 01

Sep 2026

29 - 01

Sep 2026

10th IPF Summit 2026

Boston, MA, USA

LATEST NEWSRead more...

QurCan Therapeutics Enters into Collaboration with Lilly Advance Nucleic Acid Therapies for Nervous System Diseases

QurCan Therapeutics has entered into an exclusive research and collaboration agreement with Eli Lilly and Company to develop nucleic acid therapies for diseases affecting the central nervous system CNS and peripheral nervous system PNS

BostonGene Expands Collaboration with Dana-Farber Cancer Institute for Breast Cancer Research

BostonGene has expanded its scientific collaboration with DanaFarber Cancer Institute to study the biological mechanisms involved in breast cancers associated with BRCA and BRCA mutations

Telix Receives Approval for Pixclara for Brain Cancer Imaging

Telix Pharmaceuticals has received approval from the US Food and Drug Administration FDA for Pixclara floretyrosine F or FFET a radioactive diagnostic drug used with positron emission tomography PET to image gliomas a type of brain cancer

Evonik Expands Biotechnology Manufacturing Capacity in Slovakia

Evonik has started construction of a biotechnology expansion at its Fermas site in Slovensk upa Slovakia

CordenPharma Expands Aseptic Fill-Finish Capacity to 500 Million Sterile Injectable Units Annually

CordenPharma is expanding its sterile injectable manufacturing capacity at its Caponago site in Milan Italy through a multiyear investment programme

Exegenesis Bio Enters into Collaboration with Modalis to Advance MDL-201 for Duchenne Muscular Dystrophy

Exegenesis Bio and Modalis Therapeutics have entered into a research collaboration and licence agreement to advance MDL an investigational treatment for Duchenne muscular dystrophy DMD